TY - JOUR
T1 - Borrelia burgdorferi BmpA is a laminin-binding protein
AU - Verma, Ashutosh
AU - Brissette, Catherine A.
AU - Bowman, Amy
AU - Stevenson, Brian
PY - 2009/11
Y1 - 2009/11
N2 - The Borrelia burgdorferi BmpA outer surface protein plays a significant role in mammalian infection by the Lyme disease spirochete and is an important antigen for the serodiagnosis of human infection. B. burgdorferi adheres to host extracellular matrix components, including laminin. The results of our studies indicate that BmpA and its three paralogous proteins, BmpB, BmpC, and BmpD, all bind to mammalian laminin. BmpA did not bind mammalian type I or type IV collagens or fibronectin. BmpA-directed antibodies significantly inhibited the adherence of live B. burgdorferi to laminin. The laminin-binding domain of BmpA was mapped to the carboxy-terminal 80 amino acids. Solubilized collagen inhibited BmpA-laminin binding, suggesting interactions through the collagen-binding domains of laminin. These results, together with previous data, indicate that BmpA and its paralogs are targets for the development of preventative and curative therapies for Lyme disease.
AB - The Borrelia burgdorferi BmpA outer surface protein plays a significant role in mammalian infection by the Lyme disease spirochete and is an important antigen for the serodiagnosis of human infection. B. burgdorferi adheres to host extracellular matrix components, including laminin. The results of our studies indicate that BmpA and its three paralogous proteins, BmpB, BmpC, and BmpD, all bind to mammalian laminin. BmpA did not bind mammalian type I or type IV collagens or fibronectin. BmpA-directed antibodies significantly inhibited the adherence of live B. burgdorferi to laminin. The laminin-binding domain of BmpA was mapped to the carboxy-terminal 80 amino acids. Solubilized collagen inhibited BmpA-laminin binding, suggesting interactions through the collagen-binding domains of laminin. These results, together with previous data, indicate that BmpA and its paralogs are targets for the development of preventative and curative therapies for Lyme disease.
UR - http://www.scopus.com/inward/record.url?scp=70350450260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350450260&partnerID=8YFLogxK
U2 - 10.1128/IAI.01420-08
DO - 10.1128/IAI.01420-08
M3 - Article
C2 - 19703983
AN - SCOPUS:70350450260
SN - 0019-9567
VL - 77
SP - 4940
EP - 4946
JO - Infection and Immunity
JF - Infection and Immunity
IS - 11
ER -